Universität zu Köln

Bartke, Leandra (2023). Drug combination studies of EZH2 inhibition combined with ATM, PI3-Kinase and CDK inhibitors in BRCA1-deficient breast tumors. PhD thesis, Universität zu Köln.

Ratz, Leonie, Brambillasca, Chiara, Bartke, Leandra, Huetzen, Maxim A., Goergens, Jonas, Leidecker, Orsolya, Jachimowicz, Ron D., van de Ven, Marieke, Proost, Natalie, Siteur, Bjorn, de Korte-Grimmerink, Renske, Bouwman, Peter ORCID: 0000-0002-9252-5896, Pulver, Emilia M., de Bruijn, Roebi, Isensee, Joerg, Hucho, Tim ORCID: 0000-0002-4147-9308, Pandey, Gaurav, van Lohuizen, Maarten, Mallmann, Peter, Reinhardt, Hans Christian, Jonkers, Jos ORCID: 0000-0002-9264-9792 and Puppe, Julian (2022). Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Res., 24 (1). LONDON: BMC. ISSN 1465-542X